A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Shreyansh Shah, MD
Abbott
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Melbourne Ivf
East Melbourne, Australia
- Ivf Australia - St George Private Hospitalivf Australia - St George Private Hospital
Kogarah, Australia
- Univerité Catholique de Louvain, Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Algemeen Ziekenhuis Jan Palfijn Gent
Ghent, Belgium
- Uz Gent
Ghent, Belgium
- Universitair Ziekenhuis Brussel
Jette, Belgium
- Peking University People'S Hospital
Beijing, China
- Reproductive & Genetic Hospital of Citic -Xiangya
Changsha, China
- West China Second University Hospital
Chengdu, China
- Sun Yat-Sen Memorial Hsopiatl, Sun Yat-Sen University
Guangzhou, China
- the Sixth Hospital of Sun Yat-Sen University
Guangzhou, China
- the First Affiliate Hospital of Anhui Medical University
Hefei, China
- the First Affiliated Hospital of Nanjing Medical University
Nanjing, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, China
- First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
- Fertility Center Berlin
Berlin, Germany
- Bielefeld Fertility Center
Bielefeld, Germany
- Kinderwunschzentrum Dortmund
Dortmund, Germany
- Universitäres Kinderwunschzentrum Lübeck
Lübeck, Germany
- Queen Mary Hospital
Hong Kong, Hong Kong
- United Ciigma Hospital
Aurangabad, India
- Apollo Hospitals - Bangalore
Bangalore, India
- Milann (bangalore Assisted Conception Center)
Bangalore, India
- All India Institute of Medical Sciences
Delhi, India
- Max Hospital
Delhi, India
- Institute of Reproductive Medicine
Kolkata, India
- Ajanta Research Center, Ajanta Hospital and Ivf Center
Lucknow, India
- Inamdar Multispecialty Hospital
Pune, India
- Shree Hospital and Diagnostic Centre
Pune, India
- Cjsc "nasledniki"
Moscow, Russia
- Scientific Research Center of Obstetrics, Gynecology and Perinatology N. A. Ac. V. I. Kulakova
Moscow, Russia
- Saint-Petersburg State Budgetary Healtcare Institution "maternity Hospital # 17"
Saint Petersburg, Russia
- Cjsc "center of Family Medicine"
Yekaterinburg, Russia
- Singapore General Hospital
Singapore, Singapore
- Songklanagarind Hospital
Bangkok, Thailand
- Maharaj Nakorn Chiang Mai Hospital
Chiang Mai, Thailand
- Medical Centre of Infertility Treatment "clinic of Professor Yuzko"
Chernivtsi, Ukraine
- "mother and Child" Clinic
Kiev, Ukraine
- "nadiya" Clinic
Kiev, Ukraine
- the Institute for Reproductive Medicine in Ukraine
Kiev, Ukraine
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2015
- Primary completion
- 31 May 2017
- Completion
- 31 May 2017
- Last update posted
- 1 Oct 2019
- Registered enrollment
- 1,034
- Registry id
- NCT02491437
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.